Riskpilot← Back to searchSign inGet full accessIsorea AB
ABActiveOrg 5569810285Solnavägen 9 Room A0951Research and experimental development on natural sciences and engineering · NACE 7210Est. 20141-4 employees
Revenue 2024
SEK 1
-100% vs 2023
EBITDA margin
-25064300.0%
-123% vs 2023
Equity ratio
7.9%
Financial strength
Net profit 2024
SEK -546K
-189% vs 2023
| Revenue | SEK 1 | -100% |
| EBITDA | SEK -251K | -123% |
| Net profit | SEK -546K | -189% |
| Total assets | SEK 1M | -43% |
| Equity | SEK 80K | -87% |
| Employees | — | — |
Legal name
Isorea AB
Org number
5569810285
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28 augusti 2014
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Företaget ska: inom utveckla diagnostiska kit, molekylär biometri, allmän biologi och kemi - bedriva forskning - handla med patent.
Address
Solnavägen 9 Room A0951
Email
sourav@isorea.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 1 489 | 0 |
| Staff expenses | — | — | — | −30 | −705 |
| EBITDA | 0 | −1 | −1 | 1 077 | −251 |
| Depreciation & amort. | — | −0 | −0 | — | — |
| EBIT | 0 | −1 | −1 | 1 077 | −251 |
| Net financials | — | — | — | −18 | −571 |
| Profit before tax | 0 | −1 | −1 | 784 | −546 |
| Tax | — | −0 | −0 | −170 | — |
| Net profit | — | −1 | −1 | 613 | −546 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 13 | 12 | 1 778 | 1 009 |
| Equity | — | 13 | 12 | 626 | 80 |
| Long-term debt | — | 0 | 0 | 618 | 655 |
| Short-term debt | — | 0 | 0 | 259 | 274 |
| Total debt | — | — | — | 877 | 929 |
EBITDA margin
-25064300.0%
This company
15.8%
Market median
-158634910% vs market
20202024
Equity ratio
7.9%
This company
38.2%
Market median
-79% vs market
20202024
Return on equity
-682.6%
This company
18.4%
Market median
-3810% vs market
20202024
Net profit margin
-54565100.0%
This company
8.1%
Market median
-673643310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
11.62×
This company
0.62×
Market median
-1774% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AZ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
SP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
JW Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Isorea AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jijing Wang | Deputy Chief Executive Officer | 0 companies |
| Alexander Zubarev | Deputy Chief Executive Officer | 0 companies |
| Sourav Prasanna Mukherjee | Chief Executive Officer | 0 companies |
| Roman Zoubarev | Chairman | 0 companies |